[ Price : $8.95]
FDA places a clinical hold on three CARsgen Therapeutics clinical trials due to chemistry, manufacturing and controls questions ra...[ Price : $8.95]
Four stakeholders submit specific technical concerns about an FDA draft guidance on topical ophthalmic drug quality considerations...[ Price : $8.95]
FDA approves a U.S. WorldMeds NDA for eflornithine for reducing the risk of relapse in certain adult and pediatric patients with h...[ Price : $8.95]
Sens. Durbin and Blumenthal ask the Government Accountability Office to update its 2011 report on FDA oversight of medical device ...[ Price : $8.95]
FDA warns Northridge, CA-based Novid Group that it is illegally distributing an unapproved and misbranded over-the-counter antihis...[ Price : $8.95]
Vertex Pharmaceuticals says it will advance selective NaV1.8 inhibitor VX-548 into pivotal Phase 3 studies based on positive resul...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Advanced Manufacturing Technologies Designation Program.[ Price : $8.95]
Federal Register notice: FDA creates the Genetic Metabolic Diseases Advisory Committee to review and make recommendations on inves...